-
EP4074323
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4074323
| EP4074323 - INHIBITING OR ALLEVIATING AGENT FOR A BETA-INDUCED DAMAGE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.09.2022 Database last updated on 19.10.2024 | Most recent event Tooltip | 28.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Liu, Jun Department of Neurology Sun Yat-Sen Memorial Hospital Sun Yat-Sen University Guangzhou, Guangdong 510120 / CN | For all designated states Nippon Zoki Pharmaceutical Co., Ltd. 2-3, Hiranomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0046 / JP | [2022/42] | Inventor(s) | 01 /
LIU, Jun Guangdong, 510120 / CN | [2022/42] | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [2022/42] | Application number, filing date | 22174964.1 | 06.03.2017 | [2022/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4074323 | Date: | 19.10.2022 | Language: | EN | [2022/42] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.09.2022 | Classification | IPC: | A61K35/36, A61K35/00, A61P25/16 | [2022/42] | CPC: |
A61P25/16 (EP,CN);
G01N33/5023 (CN,KR);
G01N33/6872 (CN,KR);
A61K35/36 (EP,CN,US);
A61K9/0019 (CN,US);
A61K9/0053 (CN,US);
A61P25/28 (CN,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/42] | Title | German: | MITTEL ZUR HEMMUNG ODER LINDERUNG VON BETA-INDUZIERTEN SCHÄDEN | [2022/42] | English: | INHIBITING OR ALLEVIATING AGENT FOR A BETA-INDUCED DAMAGE | [2022/42] | French: | AGENT INHIBITEUR OU ATTÉNUANT POUR DOMMAGES INDUITS PAR A BETA | [2022/42] | Examination procedure | 23.05.2022 | Examination requested [2022/42] | 18.04.2023 | Amendment by applicant (claims and/or description) | 18.04.2023 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP17899766.4 / EP3592369 | Fees paid | Renewal fee | 23.05.2022 | Renewal fee patent year 03 | 23.05.2022 | Renewal fee patent year 04 | 23.05.2022 | Renewal fee patent year 05 | 23.05.2022 | Renewal fee patent year 06 | 23.03.2023 | Renewal fee patent year 07 | 27.03.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP2364711 (VANWORLD PHARMACEUTICAL RUGAO CO LTD [CN])[A] 1-8; | [X] - FUKUDA Y ET AL, "Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin", MOLECULAR AND CELLULAR NEUROSCIENCES, SAN DIEGO, US, vol. 45, no. 3, ISSN 1044-7431, (20101101), pages 226 - 233, (20100628), XP027279150 [X] 1-8 * Introduction, page 228-right-hand column, paragraph 2, page 231, left-hand column, paragraph 2, figures 4 and 5, discussion; * | by applicant | WO2016194816 | - FUKUDA YBERRY TLNELSON M et al., "Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin", Mol Cell Neurosci, (20100000), vol. 45, pages 226 - 233, XP027279150 | - NAKAJO Y, YANG D, TAKAHASHI JC, ZHAO Q, KATAOKA H, YANAMOTO H, "ERV enhances spatial learning and prevents the development of infarcts, accompanied by upregulated BDNF in the cortex", Brain Res, (20150000), vol. 1610, doi:10.1016/j.brainres.2015.03.042, pages 110 - 123, XP029223152 DOI: http://dx.doi.org/10.1016/j.brainres.2015.03.042 | - KIMURA H, NAKAMURA S, OKAMOTO K, TOYAMA I, WATANABE M, IKEUCHI K, "A pilot study for clinical applications of Neurotropin to senile patients with dementia", Pharmacol Ther, (19870000), vol. 15, pages 407 - 423 | - HOSHINO YNAKAMURA TSATO AMISHIMA MYODOI JNAKAMURA H, "Neurotropin demonstrates cytoprotective effects in lung cells through the induction of thioredoxin-1", Am J Resp Cell Mol, (20070000), vol. 37, doi:10.1165/rcmb.2006-0402OC, pages 438 - 446, XP002555409 DOI: http://dx.doi.org/10.1165/rcmb.2006-0402OC | - LIU JLI LSUO WZ, "HT22 hippocampal neuronal cell line possesses functional cholinergic properties", Life Sci, (20090000), vol. 84, pages 267 - 271 | - ZHAO ZYLUAN PHUANG SX et al., "Edaravone protects HT22 neurons from H20 -induced Apoptosis by Inhibiting the MAPK Signaling Pathway", CNS Neurosci Ther, (20130000), vol. 19, pages 163 - 169 | - FAN SZHANG BLUAN P et al., "PI3K/AKT/mTOR/p70S6K Pathway is involved in Ap25-35-induced autophagy", Biomed Res Int, (20150000), vol. 2015, pages 1 - 9 | - ZHAO ZYLUAN PHUANG SX et al., "Edaravone protects HT22 neurons from H 0 -induced Apoptosis by Inhibiting the MAPK Signaling Pathway", CNS Neurosci Ther, (20130000), vol. 19, pages 163 - 169 | - BAO FXSHI HYQI L et al., "Mitochondrial Membrane Potential-dependent Endoplasmic Reticulum Fragmentation is an Important Step in Neuritic Degeneration", CNS Neurosci Ther, (20160000), vol. 22, pages 648 - 660 | - SCHWAB CSTEELE JCMCGEER PL, "Dystrophic neurites are associated with the majority of early stage extracellular neurofibrillary tangles in parkinsonism dementia complex of Guam", Acta Neuropathol, (19970000), vol. 94, pages 486 - 492 | - SCHWAB CHOSOKAWA MMCGEER PL, "Transgenic mice overexpressing amyloid beta protein are an incomplete model of alzheimer disease", Exp Neurol, (20040000), vol. 188, doi:10.1016/j.expneurol.2004.03.016, pages 52 - 64, XP004620642 DOI: http://dx.doi.org/10.1016/j.expneurol.2004.03.016 |